Prestige Consumer Healthcare Receivables 2010-2024 | PBH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Prestige Consumer Healthcare receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Prestige Consumer Healthcare receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$231B
Boston Scientific (BSX)	$155.5B
Stryker (SYK)	$147.4B
EssilorLuxottica (ESLOY)	$140.8B
Medtronic (MDT)	$112.8B
Lonza Group Ag (LZAGY)	$47.1B
Haleon (HLN)	$44.8B
GE HealthCare Technologies (GEHC)	$42.1B
Agilent Technologies (A)	$39B
ResMed (RMD)	$34.2B
Terumo (TRUMY)	$26.3B
Koninklijke Philips (PHG)	$23.5B
Zimmer Biomet Holdings (ZBH)	$20.6B
Insulet (PODD)	$20.2B
Baxter (BAX)	$17.1B
Sunny Optical Technology (SNPTF)	$11.3B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$9.5B
Bio-Rad Laboratories (BIO)	$8B
Demant (WILYY)	$7.9B
Lantheus Holdings (LNTH)	$5.6B
ICU Medical (ICUI)	$4B
Envista Holdings (NVST)	$3.7B
Perrigo (PRGO)	$3.4B
Haemonetics (HAE)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B
LeMaitre Vascular (LMAT)	$2.3B
Neogen (NEOG)	$2.2B